Orbital Infections 

  • Author: Keith A Lafferty, MD; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Oct 31, 2011
 

Background

Infections of the orbit are uncommon, but they are potentially devastating infections that can quickly result in blindness, meningitis, or death. The emergency physician must make a rapid and accurate diagnosis and then quickly initiate therapy because visual loss is associated directly with the length of time to definitive treatment.

Next

Pathophysiology

The orbit is a pyramid-shaped bony space in the anterior skull that contains the globe, the blood vessels, and the intraorbital muscles and nerves. The space is bordered on its superior, medial, and inferior sides by the facial sinuses (frontal, ethmoid and sphenoid, and maxillary, respectively). Note, the frontal sinuses normally develop at the age of 8 years and are not fully developed until puberty. The bony septa separating the orbit from the sinuses are thin and fenestrated, particularly in the medial orbital wall, where the lamina papyracea borders the ethmoid sinus.

The anterior border of the orbit is marked by the orbital septum, a fibrous band from the external bony orbit to both eyelids (specifically from the periosteum of the orbital rim to the levator aponeurosis in the upper eyelid and to the inferior border of the tarsal plate in the lower eyelid), which effectively separates the preseptal space from the orbital space. This is actually contiguous with the periosteum that is reflected into the upper and lower lids. The posterior wall of the orbit contains the optic canal and the superior and inferior orbital fissures. The superior orbital fissure connects directly to the cavernous sinus and the intracranial space. The facial veins drain directly into the valveless superior and inferior ophthalmic veins. These, in turn, drain via many anastomoses into the cavernous sinus. The posterior wall is the source of the blood and nerve supply to the orbit.

The optic nerve (cranial nerve [CN] II) enters the orbit with the ophthalmic artery through the optic canal. CNs III, IV, and VI; the ophthalmic branch of the trigeminal nerve (CN V1); and the superior ophthalmic vein enter the cavernous sinus after exiting the orbit through the superior orbital fissure.

The superior ophthalmic vein provides the main venous drainage for the contents of the orbit. The smaller inferior ophthalmic vein exits the orbit through the inferior orbital fissure with the maxillary branch of the trigeminal nerve (CN V2) and connects with the temporal fossa.

Orbital infections develop via direct inoculation, extension from adjacent structures, and hematogenous spread. Sixty percent of these infections develop from the direct spread of sinusitis, with the ethmoid sinus being the most commonly implicated.

Infections also can spread from the preseptal space, particularly from preseptal (or periorbital) cellulitis in children, as well as from the pharynx, middle ear, facial skin, nose, lacrimal gland (dacryocystitis), or dentition. The ease and rapidity of such infectious spread relates to the facial venous system, which has a great number of anastomoses and is entirely valveless.

Infectious material can be inoculated directly into the orbital soft tissue secondary to trauma, surgery, or orbital foreign bodies. More rarely, orbital infections develop from hematogenous seeding secondary to sepsis or bacterial endocarditis.

Orbital infections are classified by a 5-tier system, as described by Smith and Spencer and modified by Chandler et al.

  • Group I - Preseptal cellulitis
  • Group II - Orbital cellulitis
  • Group III - Subperiosteal abscess
  • Group IV - Orbital abscess
  • Group V - Cavernous sinus thrombosis

This classification system does not necessarily imply an order of disease progression; however, it helps explain the physical signs and symptoms of the various infections and helps organize treatment plans. Preseptal (or periorbital) cellulitis, which is an inflammatory edema of the eyelids and periorbital skin with no involvement of the orbit, comprises the first group. Orbital signs (eg, chemosis, proptosis, visual loss) are not present in this infection. Preseptal cellulitis may extend posteriorly, owing to the valveless communication of the facial and ophthalmic veins to the cavernous sinus, to produce one of the intraorbital infections (groups II-V).

Orbital cellulitis is an infection of the soft tissue of the orbit without abscess formation. It is a well-known complication of paranasal sinusitis, as well as periodontal abscesses, nasolacrimal infections, trauma, postsurgical infections, and rhabdomyosarcomas. Patients with this infection may develop orbital signs and symptoms (eg, chemosis, visual loss), and they often have more systemic toxicity than patients with preseptal cellulitis. Direct orbit CT scan has increased in its sensitivity over the years for diagnosing this entity. Most cases will show edema with or without microabscesses.

Orbital cellulitis may or may not progress to a significant subperiosteal abscess, orbital abscess, or cavernous sinus thrombosis.

Subperiosteal abscesses are collections of purulent material between the orbital bony wall and periosteum. This entity may develop in 7-9% of patients initially with orbital cellulitis or from spread of an adjacent infection, as occurs when ethmoid sinusitis spreads to the medial orbital subperiosteal space. This diagnosis is confirmed by CT scan, but it can be suspected based on physical examination. In addition to signs of orbital involvement (eg, chemosis, visual loss), limitations of ocular motility and directional proptosis may be present from the intraorbital mass effect and entrapment of the extraocular muscles.

Orbital abscesses are collections of pus within the orbital soft tissue. Diagnosis is confirmed by CT scan, but the physical signs of severe exophthalmos and chemosis, with complete ophthalmoplegia, as well as venous engorgement or papilledema on funduscopic examination, are suggestive.

Orbital infections. Orbital abscess with significaOrbital infections. Orbital abscess with significant proptosis.

These infections usually are secondary to orbital cellulitis and sometimes can be differentiated from orbital cellulitis by the occurrence of the orbital apex syndrome. This syndrome is a collection of signs and symptoms consistent with organized infection in the posterior orbit (specifically, compression of the superior orbital fissure), and it is highly suggestive of group IV or V disease.

Signs include unilateral ptosis, proptosis, visual loss, internal and external ophthalmoplegia (ie, palsy of the pupillary and extraocular muscles), and CN V1 (forehead) anesthesia. Orbital cellulitis may or may not progress to cavernous sinus thrombosis.

Cavernous sinus thrombosis (CST) is an infectious thrombosis of the cavernous sinus and, although seen in only 1% of progressive orbital cellulitis cases, it carries a mortality rate of up to 50%. The cavernous sinus, a circular venous structure surrounding the pituitary gland, drains blood from both orbits. Although the incidence is low, CST is a serious complication of untreated orbital infections and infectious thrombosis most commonly spread from the orbit via communicating orbital veins into the cavernous sinus. Infectious CST is characterized by headache, high fever, periorbital edema, proptosis, chemosis, and paralysis of eye movements. Once again, this diagnosis is confirmed by CT scan or MRI; however, the physical sign of bilateral posterior orbital disease is highly suggestive.

Bilateral involvement occurs because the right and left ophthalmic veins drain into the same contiguous sinus. Since the cavernous sinus is connected through the midline, thrombosis of one side may thrombose the other side. Complete internal and external ophthalmoplegia often is produced when thrombosis of the sinus causes palsy of CNs III, IV, V1, and the sympathetic fibers as they travel through prior to entry into the orbit. CN VI is most susceptible owing to its long course and narrow diameter. In addition, this may be explained by the susceptibility of the abducent nerve to intracavernous pathology because of its intraluminal course. Note the image below.

Cavernous sinus and its cranial nerves. Cavernous sinus and its cranial nerves.

To fully understand CST, one must be reminded of its unique vascular connections. This dural sinus, like all dural sinuses, has no valves. Because of this, blood flows in either direction because of pressure gradients in the vascular system. Additionally, the CST receives many connections from potentially vulnerable, centrally located facial structures. Septic thrombosis can develop from infected tributary sites such as the face, nose, soft palate, tonsils, teeth, and ears. Note that the wide use of antibiotic therapy for infections involving the stated structures has allowed an increasing emergence of sphenoid sinusitis–induced CST.

The distinction between infectious thrombosis and orbital infection alone is important because the treatment of cavernous sinus thrombosis may involve the addition of anticoagulation therapy to the antibiotic therapy. The use of anticoagulation therapy in sinus thrombosis remains controversial because of concerns with safety, as it may precipitate a hemorrhagic infarct.[1, 2]

Intracranial infection or cavernous sinus thrombosis can result from any stage of orbital infections.

Previous
Next

Epidemiology

Mortality/Morbidity

Sex

Males are affected slightly more often than females.

Age

  • Orbital infections are more common in persons younger than 19 years. In fact, bacteremic periorbital cellulitis is most often seen in infants younger than 18 months of age.
  • Orbital infections are more severe in adults.
Previous
 
 
Contributor Information and Disclosures
Author

Keith A Lafferty, MD  Adjunct Assistant Professor of Emergency Medicine, Temple University; Consulting Staff, Department of Emergency Medicine, South West Regional Medical Center

Keith A Lafferty, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Medical Association, and Pennsylvania Medical Society

Disclosure: Nothing to disclose.

Coauthor(s)

Keisha Bonhomme  Ross University School of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Eric M Kardon, MD, FACEP  Attending Emergency Physician, Georgia Emergency Medicine Specialists; Physician, Division of Emergency Medicine, Athens Regional Medical Center

Eric M Kardon, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Eric L Weiss, MD, DTM&H  Medical Director, Office of Service Continuity and Disaster Planning, Fellowship Director, Stanford University Medical Center Disaster Medicine Fellowship, Chairman, SUMC and LPCH Bioterrorism and Emergency Preparedness Task Force, Clinical Associate Progressor, Department of Surgery (Emergency Medicine), Stanford University Medical Center

Eric L Weiss, MD, DTM&H is a member of the following medical societies: American College of Emergency Physicians, American College of Occupational and Environmental Medicine, American Medical Association, American Society of Tropical Medicine and Hygiene, Physicians for Social Responsibility, Southeastern Surgical Congress, Southern Association for Oncology, Southern Clinical Neurological Society, and Wilderness Medical Society

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author, Robert G Hendrickson, MD, to the development and writing of this article.

References
  1. Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature. J Laryngol Otol. Sep 2002;116(9):667-76. [Medline].

  2. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. Apr 28 2005;352(17):1791-8. [Medline].

  3. Ambati BK, Ambati J, Azar N. Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. Ophthalmology. Aug 2000;107(8):1450-3. [Medline].

  4. Seltz LB, Smith J, Durairaj VD, Enzenauer R, Todd J. Microbiology and antibiotic management of orbital cellulitis. Pediatrics. Mar 2011;127(3):e566-72. [Medline].

  5. Freidlin J, Acharya N, Lietman TM, Cevallos V, Whitcher JP, Margolis TP. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. Aug 2007;144(2):313-5. [Medline].

  6. McKinley SH, Yen MT, Miller AM, Yen KG. Microbiology of pediatric orbital cellulitis. Am J Ophthalmol. Oct 2007;144(4):497-501. [Medline].

  7. Blomquist PH. Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:322-45. [Medline]. [Full Text].

  8. Mills DM, Tsai S, Meyer DR, Belden C. Pediatric ophthalmic computed tomographic scanning and associated cancer risk. Am J Ophthalmol. Dec 2006;142(6):1046-53. [Medline].

  9. Younis RT, Anand VK, Davidson B. The role of computed tomography and magnetic resonance imaging in patients with sinusitis with complications. Laryngoscope. Feb 2002;112(2):224-9. [Medline].

  10. Parmar H, Gandhi D, Mukherji, SK, Trobe JD. Restricted Diffusion in the Superior Ophthalmic Vein and Cavernous Sinus in a Case of Cavernous Sinus Thrombosis. J Neuro-Ophthalmol. 2009;29;1:16-20. [Medline].

  11. Sepahdari AR, Aakalu VK, Kapur R, Michals EA, Saran N, French A, et al. MRI of orbital cellulitis and orbital abscess: the role of diffusion-weighted imaging. AJR Am J Roentgenol. Sep 2009;193(3):W244-50. [Medline].

  12. Hennemann S, Crawford P, Nguyen L, Smith PC. Clinical inquiries. What is the best initial treatment for orbital cellulitis in children?. J Fam Pract. Aug 2007;56(8):662-4. [Medline].

  13. Donahue SP, Schwartz G. Preseptal and orbital cellulitis in childhood. A changing microbiologic spectrum. Ophthalmology. Oct 1998;105(10):1902-5; discussion 1905-6. [Medline].

  14. Farnath D. Ocular infections. In: Infectious Disease in Emergency Medicine. 2nd ed. 1998:843-58.

  15. Ghezzi K, Renner GS. Ophthalmologic disorders. In: Emergency Medicine. Concepts and Clinical Practice. 1992:2427-59.

  16. Gordon LK. Diagnostic dilemmas in orbital inflammatory disease. Ocul Immunol Inflamm. Mar 2003;11(1):3-15. [Medline].

  17. Hendrickson RG, Olshaker J, Duckett O. Rhinocerebral mucormycosis: a case of a rare, but deadly disease. J Emerg Med. Jul-Aug 1999;17(4):641-5. [Medline].

  18. Kraus DJ, Bullock JD. Orbital infections. In: Pepose JS, Holland G, Wilheimus K, eds. Ocular Infection and Immunity. Mosby-Year Book; 1996:1321-40.

  19. Prentiss KA, Dorfman DH. Pediatric ophthalmology in the emergency department. Emerg Med Clin North Am. Feb 2008;26(1):181-98, vii. [Medline].

  20. Rumelt S, Rubin PA. Potential sources for orbital cellulitis. Int Ophthalmol Clin. Summer 1996;36(3):207-21. [Medline].

  21. Wald ER. Periorbital and orbital infections. Infect Dis Clin North Am. Jun 2007;21(2):393-408, vi. [Medline].

  22. Westfall CT, Shore JW, Baker AS. Orbital infections. In: Infectious Diseases. 2nd ed. 1373-7.

  23. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. Jul-Aug 1994;39(1):3-22. [Medline].

Previous
Next
 
Complications of orbital infections. Brain abscess in a young man secondary to an orbital infection from Mucor species.
Orbital infections. Orbital abscess with significant proptosis.
Orbital infections. Subperiosteal abscess with contiguous sinusitis.
Orbital infections. Subperiosteal abscess with contiguous sinusitis.
Orbital infections. Frontal sinusitis.
Orbital infections. Orbital abscess with significant proptosis.
Cavernous sinus and its cranial nerves.
Orbital cellulitis; chemosis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.